Rotigotine

Details

Files

Generic Name:

Rotigotine

Project Status:

Complete

Therapeutic Area:

Parkinson’s disease

Manufacturer:

UCB Canada Inc.

Call for patient/clinician input open:

April 23, 2015

Brand Name:

Neupro

Project Line:

Reimbursement Review

Project Number:

SR0432-000

Call for patient/clinician input closed:

June 12, 2015

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Resubmission

Indications:

Parkinson’s Disease

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

November 19, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : April 23, 2015